I appreciate your effort at this because as you know, I once suggested that there might have been a stealth crossover by SOC to treatment which would have had to remain very quiet. Lykiri assured me this did not happen so your analysis of the sensors kind of hits home with me about what might have really happened. Bottom line is that some patients were purposely left out of all of the published data and analysis to date and more of an explanation is to be expected at some point. Again, I appreciate your attempt to interpret this. Best wishes.
German col, it is hard for me to wrap my head around the problem as to how the group of 35 (that were distinct from the group of 64 crossovers) were divided up. From Dr. Liau's Q&A period I got the impression that there were 6-7 LTFU in that group and she did not specify whether any of them were Pseudos who crossed over. That leaves about 28-29 patients of whom you say many of them were Pseudos who crossed over ( censored) and that leaves some poor OS performing patients who were permanent placebos
We really need more information about those 35 patients although it looks to me that none of those 35 can contribute anything statistically to this trial.